Evozyne

About:

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Twitter/X: evozyne

Top Investors: Fidelity, NVentures, OrbiMed, Paragon Biosciences, Valor Equity Partners

Description:

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development. It is a biotechnology company that specializes in protein design and molecular scale. Its mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design. It was founded in 2020 and is headquartered in Chicago, Illinois.

Total Funding Amount:

$144M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2020-01-01

Founders:

Andrew Ferguson, Jeff Aronin, Rama Ranganathan

Number of Employees:

51-100